Engineered immune cells take aim at stubborn autoimmune diseases
Disease control
Not yet recruiting
This early study will test a new treatment called CD19/BCMA CAR-T in 20 adults with severe autoimmune diseases like lupus or Sjögren's syndrome that haven't improved with standard therapies. The treatment uses a patient's own immune cells, modified in a lab to target and attack f…
Phase: NA • Sponsor: Shenzhen Genocury Biotech Co., Ltd. • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC